Use of in vitro data in developing a physiologically based pharmacokinetic model: Carbaryl as a case study.
about
Analysis of biomarker utility using a PBPK/PD model for carbaryl.Addressing Early Life Sensitivity Using Physiologically Based Pharmacokinetic Modeling and In Vitro to In Vivo Extrapolation.Prediction of metabolism-induced hepatotoxicity on three-dimensional hepatic cell culture and enzyme microarrays.High-throughput analysis using non-depletive SPME: challenges and applications to the determination of free and total concentrations in small sample volumes.
P2860
Use of in vitro data in developing a physiologically based pharmacokinetic model: Carbaryl as a case study.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Use of in vitro data in develo ...... del: Carbaryl as a case study.
@ast
Use of in vitro data in develo ...... del: Carbaryl as a case study.
@en
type
label
Use of in vitro data in develo ...... del: Carbaryl as a case study.
@ast
Use of in vitro data in develo ...... del: Carbaryl as a case study.
@en
prefLabel
Use of in vitro data in develo ...... del: Carbaryl as a case study.
@ast
Use of in vitro data in develo ...... del: Carbaryl as a case study.
@en
P2093
P1433
P1476
Use of in vitro data in develo ...... odel: Carbaryl as a case study
@en
P2093
Grace Zhixia Yan
Gregory L Kedderis
Harvey J Clewell
P356
10.1016/J.TOX.2014.05.006
P407
P50
P577
2014-05-24T00:00:00Z